Tweets
In case you missed it…
RA: Still a Clinical Diagnosis
https://t.co/8RrhxAgbkP https://t.co/R9EpxSE9Gr
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
ICYMI: Positive Results from the DOA (Duloxetine in OsteoArthritis) Study
https://t.co/JU0OeQgmta https://t.co/IRv3C747Zt
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
New podcast available for download!
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. This week, rheumatologic problems incited by respiratory infections, air pollution and how you live, now where you live.
https://t.co/jQAq6iBvca https://t.co/FgIG1ogPGo
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
We are excited to share that Kaleb Michaud, PhD, will be presenting on Adherence to Rheumatoid Therapies during our RA-Future Improvement Pod at RheumNow Live on 3/19.
Have you registered yet?
https://t.co/HOOMh84MF0 https://t.co/5lPijPoN9b
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
MMWR - NFL Study on When to Be Released if COVID(+)
MMWR has reported the results of the National Football Leagues (NFL) change in SARS-CoV-2 testing program that went into effect in December 2021.
https://t.co/EoIjc0XL0R https://t.co/ysRPao1oC2
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
COSMOS Study - Guselkumab Efficacy at 1 Year in Psoriatic Arthritis
https://t.co/kl6RzE6hK2 https://t.co/vLY2xQAqwn
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
FDA granted Breakthrough Therapy Designation Boehringer Ingelheims BI 1015550 - a oral, phosphodiesterase 4B inhibitor (antifibrotic & anti-inflammatory), now in phase II trials for idiopathic pulmonary fibrosis https://t.co/SMXEweSVAR
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
SLE mortality rates (ASMR) nearly doubled since 1998 & remain high (vs non-SLE mortality) w/ significant sex & regional disparities. Data from 11449 SLE deaths, ASMR signif increased 1998 to 2009, down 2009 to 2013 and increased thereafter https://t.co/kSc3Cn2Bl5
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Diagnostic delay in axial spondyloarthritis? Systematic review shows Dx delay ranged 0.67 to 8 years (>75% =,2-6 yrs). Only 1/3 had median delay ~ 2 yrs. Gender and +FamHx did not influence Dx Delay. https://t.co/R5WwCvZPzc
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Where you live doesn't alter your risk for RA. Systematic review of 54 articles, 11 studies shows that rural/remote populations had no greater #RA risk. But Rural/remote pts have >barriers to care which increases the risk for inequities in outcomes. https://t.co/8fhFSQ54rt https://t.co/qJhNFcb0b2
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Case showing flare of Dermatomyositis in a Patient With Psoriasis treated with Secukinumab. https://t.co/uvXyqONaHl
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Single center study of 957 plaque psoriasis pts and the effect of air pollutants. Overall 39% experience a PSO flare and that concentrations of all pollutants were significantly higher in the 60 days before psoriasis flare https://t.co/8Hw3LsLy8f
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
